Palladium(ii) complexes supported by tetradentate [N^C^C^N] and [O^N^C^N] ligand systems display sky blue to red phosphorescence with emission quantum yields and emission lifetimes up to 0.64 and 272 μs, respectively. Femtosecond time-resolved fluorescence (fs-TRF) measurements on these Pd(ii) complexes reveal a fast intersystem crossing from singlet to triplet manifolds with time constants of 0.6-21 ps. DFT/TDDFT calculations revealed that, as a result of the spiro-fluorene and bridging tertiary amine units of the ligands, the T1 excited state is more ligand-localized and has smaller structural distortion, leading to slower non-radiative decay as well as radiative decay of T1 → S0 transition and thereby highly emissive, long-lived triplet excited states. The Pd(ii) complexes have been found to be efficient catalysts for visible light-driven, reductive C-C bond formation from unactivated alkyl bromides with conversions and yields of up to 90% and 83%, respectively. These complexes have also been employed as photosensitizers for [2 + 2] cycloaddition of styrenes, with conversions and yields comparable to those of the reported Ir(iii) complexes. Both green and sky blue organic-light emitting devices (OLEDs) have been generated with these Pd(ii) complexes as guest emitters. Maximum external quantum efficiencies (EQE) of up to 16.5% have been achieved in the sky blue OLEDs. The long emission lifetimes render the Pd(ii) complexes good sensitizers for phosphor-sensitized fluorescent OLEDs (PSF-OLEDs). By utilizing these phosphorescent Pd(ii) complexes as sensitizers, highly efficient green and yellow PSF-OLEDs having high EQE (up to 14.3%), high colour purity and long operation lifetimes, with 90% of initial luminance (LT90) for more than 80 000 h, have been realized.
No takes yet. Share an insight, caveat, or question.
Chow et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: